Elisa

A disappointing EBITDA decline in Q3

21/10/26 -"In Q3, revenue remained stable compared to the previous year, with a slight improvement over H1. However, concerns arise from EBITDA, which decreased by 1.8% yoy. Elisa’s stock has declined ..."

PDF page sample
Pages
54
Language
English
Published on
21/10/26
Download
You may also be interested by these reports :
22/10/26
Q2 results exceeded expectations, prompting an upward revision of the 2026 outlook. EBITDA growth is now projected at 3%-4%, up from the previous 3%. ...
21/10/26
In Q3, revenue remained stable compared to the previous year, with a slight improvement over H1. However, concerns arise from EBITDA, which ...
21/10/26
Q3 results reached the upper end of the consensus range. Management has revised the guidance for total revenue growth upwards. However, Capex is now ...
20/10/26
We have lowered our revenue growth estimates slightly, and given that Eutelsat is in a significant investment phase, we believe it will take more ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO